EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma

Background Ephrin type-A receptors (EPHA) are members of family of receptor tyrosine kinases and are related to tumor immunogenicity and immune microenvironment, however, the association between EPHA mutation (EPHAmut) and efficacy of immune checkpoint inhibitors (ICIs) has not been investigated in...

Full description

Bibliographic Details
Main Authors: Jie Wang, Zhijie Wang, Jianchun Duan, Rui Wan, Jiachen Xu, Kailun Fei, Chengcheng Li, Wenzhuan Xie, Zhengyi Zhao, Shangli Cai
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001315.full

Similar Items

Similar Items